Jean-Damien Combes

Jean-Damien Combes

Auto-generated profile, based on publicly available information

Jean-Damien Combes

International Agency for Research on Cancer, Lyon, France

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 February 2019 in Radiation Oncology
Verified
Journal Article
Open access
PDF file
MFMotomasa Furuse
Motomasa Furuse
NNNaosuke Nonoguchi
Naosuke Nonoguchi
KYKei Yamada
Kei Yamada
TSTohru Shiga
Tohru Shiga
JCJean-Damien Combes
Jean-Damien Combes
SMShin-Ichi Miyatake
Shin-Ichi Miyatake
This systematic review aims to elucidate the diagnostic accuracy of radiological examinations to distinguish between brain radiation necrosis (BRN) and tumor progression (TP). We divided diagnostic approaches into two categories as follows—conventional radiological imaging [computed tomography (CT) and magnetic resonance imaging (MRI): review question (RQ) 1] and nuclear medicine studies [single photon emission CT (SPECT) and positron emission tomography (PET): RQ2]—and queried. Our librarians conducted a comprehensive systematic search on PubMed, the Cochrane Library, and the Japan Medical Abstracts Society up to March 2015. We estimated summary statistics using the bivariate random effects model and performed subanalysis by dividing into tumor types—gliomas and metastatic brain tumors. Of 188 and 239 records extracted from the database, we included 20 and 26 studies in the analysis for RQ1 and RQ2, respectively. In RQ1, we used gadolinium (Gd)-enhanced MRI, diffusion-weighted image, MR spectroscopy, and perfusion CT/MRI to diagnose BRN in RQ1. In RQ2, 201Tl-, 99mTc-MIBI-, and 99mTc-GHA-SPECT, and 18F-FDG-, 11C-MET-, 18F-FET-, and 18F-BPA-PET were used. In meta-analysis, Gd-enhanced MRI exhibited the lowest sensitivity [63%; 95% confidence interval (CI): 28–89%] and diagnostic odds ratio (DOR), and combined multiple imaging studies displayed the highest sensitivity (96%; 95% CI: 83–99%) and DOR among all imaging studies. In subanalysis for gliomas, Gd-enhanced MRI and 18F-FDG-PET revealed low DOR. Conversely, we observed no difference in DOR among radiological imaging in metastatic brain tumors. However, diagnostic parameters and study subjects often differed among the same imaging studies. All studies enrolled a small number of patients, and only 10 were prospective studies without randomization. Differentiating BRN from TP using Gd-enhanced MRI and 18F-FDG-PET is challenging for patients with glioma. Conversely, BRN could be diagnosed by any radiological imaging in metastatic brain tumors. This review suggests that combined multiparametric imaging, including lesional metabolism and blood flow, could enhance diagnostic accuracy, compared with a single imaging study. Nevertheless, a substantial risk of bias and indirectness of reviewed studies hindered drawing firm conclusion about the best imaging technique for diagnosing BRN.

1 March 2017 in Oral Oncology
Verified
Journal Article
Closed access
JCJean-Damien Combes
Jean-Damien Combes
VDVéronique Dalstein
Véronique Dalstein
TGTarik Gheit
Tarik Gheit
GCGary M. Clifford
Gary M. Clifford
MTMassimo Tommasino
Massimo Tommasino
SFSilvia Franceschi
Silvia Franceschi

13 November 2018 in Journal of Medical Virology
Verified
Journal Article
Closed access
PDF file
AKAboud Kourieh
Aboud Kourieh
TGTarik Gheit
Tarik Gheit
MTMassimo Tommasino
Massimo Tommasino
VDVéronique Dalstein
Véronique Dalstein
GCGary M. Clifford
Gary M. Clifford
FGfor the SPLIT study group
for the SPLIT study group

10 April 2018 in Infectious Agents and Cancer
Verified
Journal Article
Open access
PDF file
JCJean-Damien Combes
Jean-Damien Combes
SFSilvia Franceschi
Silvia Franceschi
Human papillomaviruses (HPV) cause infections that are responsible for diverse clinical manifestations from benign conditions to invasive cancer. As different HPV types are associated with variable pathogenic potential, minor genetic variations within a given high-risk HPV type might also be associated with distinct oncogenic capacities, through variable ability of persistence or risk of progression to precancer/cancer. Most recent HPV variant studies in the cervix using latest sequencing technology confirmed that minor changes in the HPV genome can have a major influence on carcinogenesis and have revealed key data that help better understand the carcinogenicity of HPV at a molecular level. Here we review the limited number of studies on HPV genome variants in head and neck cancers (HNC) and discuss their implications for cancer research in the light of accumulated knowledge for the cervix. Challenges in transposing HPV variant studies from the lower anogenital to the upper aerodigestive tract are also discussed, highlighting the main gaps of knowledge in the field of HPV-induced HNC. Specifically in the head and neck region, the lack of characterisation of precancerous lesions and the difficulty in sampling normal tissue will challenge the development of accurate studies. Although there is so far no indication that HPV variant research in HNC could directly translate into clinical application, such research is expected to be useful to disentangle unanswered questions in the pathogenesis of HNC. Yet, history of HPV variant research suggests that, to be successful, studies will require large international collaborative efforts.

1 December 2021 in Cancer Epidemiology
Verified
Journal Article
Closed access
MLMengmeng Li
Mengmeng Li
PDPatricia Delafosse
Patricia Delafosse
FMFilip Meheus
Filip Meheus
FBFrançoise Borson-Chazot
Françoise Borson-Chazot
JLJean-Christophe Lifante
Jean-Christophe Lifante
Salvatore VaccarellaSalvatore Vaccarella
Salvatore Vaccarella

1 December 2018 in Journal of General Virology
Verified
Journal Article
Open access
AKAboud Kourieh
Aboud Kourieh
JCJean-Damien Combes
Jean-Damien Combes
MTMassimo Tommasino
Massimo Tommasino
VDVéronique Dalstein
Véronique Dalstein
GCGary M. Clifford
Gary M. Clifford
FGfor the SPLIT study group
for the SPLIT study group
The prevalence of 13 polyomaviruses (PyVs) in the tonsil brushings and gargles of immunocompetent children and adults was assessed. Patients undergoing tonsillectomy for benign indications were recruited in 19 centres in France. After resection, the entire outer surface of the right and left halves of the tonsils was brushed extensively. Gargles were also collected prior to surgery in selected adults. A species-specific multiplex assay was used to detect the DNA of 13 PyVs. In tonsil brushings (n=689), human PyV 6 (HPyV6) and Merkel cell PyV (MCPyV) were the most prevalent (≈15 %), followed by trichodysplasia spinulosa-associated PyV (TSPyV), BKPyV, Washington University PyV (WUPyV) and human PyV 9 (HPyV9) (1 to 5 %), and human PyV 7 (HPyV7), John Cunningham PyV (JCPyV) and Simian virus 40 (SV40) (<1 %), while no Karolinska Institute PyV (KIPyV), Malawi PyV (MWPyV), human PyV 12 (HPyV12) or Lyon IARC PyV (LIPyV) were detected. The prevalence of TSPyV and BKPyV was significantly higher in children versus adults, whereas for HPyV6 the opposite was found. HPyV6 and WUPyV were significantly more prevalent in men versus women. In gargles (n=139), MCPyV was the most prevalent (≈40 %), followed by HPyV6, HPyV9 and LIPyV (2 to 4 %), and then BKPyV (≈1 %), while other PyVs were not detected. MCPyV and LIPyV were significantly more prevalent in gargles compared to tonsil brushings, in contrast to HPyV6. We described differing patterns of individual PyV infections in tonsils and gargles in a large age-stratified population. Comparison of the spectrum of PyVs in paired tonsil samples and gargles adds to the current knowledge on PyV epidemiology, contributing towards a better understanding of PyV acquisition and transmission and its potential role in head and neck diseases.